GC-MS based Gestational Diabetes Mellitus longitudinal study: Identification of 2-and 3-hydroxybutyrate as potential prognostic biomarkers
- PMID: 28314466
- DOI: 10.1016/j.jpba.2017.02.056
GC-MS based Gestational Diabetes Mellitus longitudinal study: Identification of 2-and 3-hydroxybutyrate as potential prognostic biomarkers
Abstract
Gestational Diabetes Mellitus (GDM) causes severe short- and long-term complications for the mother, fetus and neonate, including type 2-diabetes (T2DM) later in life. In this pilot study, GC-Q/MS analysis was applied for plasma metabolomics fingerprinting of 24 healthy and 24 women with GDM at different stages of gestation (second and third trimester) and postpartum (one and three months). Multivariate (unsupervised and supervised) statistical analysis was performed to investigate variance in the data, identify outliers and for unbiased assessment of data quality. Plasma fingerprints allowed for the discrimination of GDM pregnant women from controls both in the 2nd and 3rd trimesters of gestation. However, metabolic profiles tended to be similar after delivery. Follow up of these women revealed that 4 of them developed T2DM within 2 years postpartum. Multivariate PLS-DA models limited to women with GDM showed clear separation 3 months postpartum. In the 2nd trimester of gestation there was also a clear separation between GDM women that were normoglycemic after pregnancy and those with recognized postpartum T2DM. Metabolites that had the strongest discriminative power between these groups in the 2nd trimester of gestation were 2-hydroxybutyrate, 3-hydroxybutyrate, and stearic acid. We have described, that early GDM comprises metabotypes that are associated with the risk of future complications, including postpartum T2DM. In this pilot study, we provide evidence that 2-hydroxybutyrate and 3-hydroxybutyrate may be considered as future prognostic biomarkers to predict the onset of diabetic complications in women with gestational diabetes after delivery.
Keywords: 2-hydroxybutyrate; 3-hydroxybutyrate; Fingerprinting; Gas chromatography; Gestational diabetes mellitus; Maternal metabolism; Metabolomics; Type 2-diabetes mellitus.
Copyright © 2017 Elsevier B.V. All rights reserved.
Similar articles
-
Plasma metabolites, especially lipid metabolites, are altered in pregnant women with gestational diabetes mellitus.Clin Chim Acta. 2021 Jun;517:139-148. doi: 10.1016/j.cca.2021.02.023. Epub 2021 Mar 9. Clin Chim Acta. 2021. PMID: 33711327 Review.
-
Metabolic profiling of pre-gestational and gestational diabetes mellitus identifies novel predictors of pre-term delivery.J Transl Med. 2020 Sep 24;18(1):366. doi: 10.1186/s12967-020-02531-5. J Transl Med. 2020. PMID: 32972433 Free PMC article.
-
Comprehensive analysis of serum metabolites in gestational diabetes mellitus by UPLC/Q-TOF-MS.Anal Bioanal Chem. 2016 Feb;408(4):1125-35. doi: 10.1007/s00216-015-9211-3. Epub 2015 Dec 16. Anal Bioanal Chem. 2016. PMID: 26677023 Clinical Trial.
-
Metabolic fingerprint of Gestational Diabetes Mellitus.J Proteomics. 2014 May 30;103:57-71. doi: 10.1016/j.jprot.2014.03.025. Epub 2014 Mar 31. J Proteomics. 2014. PMID: 24698665
-
Gestational diabetes mellitus and subsequent development of overt diabetes mellitus.Dan Med Bull. 1998 Nov;45(5):495-509. Dan Med Bull. 1998. PMID: 9850811 Review.
Cited by
-
Neurodevelopment and Metabolism in the Maternal-Placental-Fetal Unit.JAMA Netw Open. 2024 May 1;7(5):e2413399. doi: 10.1001/jamanetworkopen.2024.13399. JAMA Netw Open. 2024. PMID: 38805224 Free PMC article.
-
Enzymatic detection of α-hydroxybutyrate, an important marker of insulin resistance, and comparison with LC-MS/MS detection.Pract Lab Med. 2024 May 6;40:e00398. doi: 10.1016/j.plabm.2024.e00398. eCollection 2024 May. Pract Lab Med. 2024. PMID: 38745675 Free PMC article.
-
Recent progress in metabolic reprogramming in gestational diabetes mellitus: a review.Front Endocrinol (Lausanne). 2024 Jan 3;14:1284160. doi: 10.3389/fendo.2023.1284160. eCollection 2023. Front Endocrinol (Lausanne). 2024. PMID: 38234430 Free PMC article. Review.
-
The role of lipid dysregulation in gestational diabetes mellitus: Early prediction and postpartum prognosis.J Diabetes Investig. 2024 Jan;15(1):15-25. doi: 10.1111/jdi.14119. Epub 2023 Dec 14. J Diabetes Investig. 2024. PMID: 38095269 Free PMC article. Review.
-
Molecular pathways and nutrigenomic review of insulin resistance development in gestational diabetes mellitus.Front Nutr. 2023 Sep 20;10:1228703. doi: 10.3389/fnut.2023.1228703. eCollection 2023. Front Nutr. 2023. PMID: 37799768 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous